U-Act-After: An Observational Study on Long-Term Efficacy of Tight Control RoActemra/Actemra (Tocilizumab) and/or Methotrexate in Patients With Early Rheumatoid Arthritis Who Have Participated in the U-Act-Early Study (ML22497)
Clinical trial NCT01918267 · COMPLETED
Trial details
- NCT number
- NCT01918267
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-04-10
- Primary completion
- 2017-10-10
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.